# Chartwell Pharmaceuticals Amityville, LLC, Amityville, NY – FDA Inspections

Source: https://www.keypedia.com/companies/chartwell-pharmaceuticals-amityville-llc/d8360380-d99c-4c6b-a098-04d0bcc0f7c1

> Inspection records and compliance data for Chartwell Pharmaceuticals Amityville, LLC in Amityville, New York. 14 FDA inspections on record (1 OAI), 2 Form 483s, last inspected December 21, 2022.

---

## Details

- Name: Chartwell Pharmaceuticals Amityville, LLC
- FEI Number: 2433247
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK, REPACK
- Address Line 1: 369 Bayview Ave
- City: Amityville
- State: New York
- Zip Code: 11701
- Country Name: United States
- Address: 369 Bayview Ave, Amityville, New York 11701, United States
- Country: United States

## Related Documents

- [483 - Chartwell Pharmaceuticals Amityville, LLC - 2022-12-21](https://www.keypedia.com/records/483/chartwell-pharmaceuticals-amityville-llc/726e0109-e40e-42ce-8c36-e43dd6c5ef08) — source: FDA, date: December 21, 2022
- FDA Inspection 1193806 - Chartwell Pharmaceuticals Amityville, LLC - 2022-12-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 21, 2022
- [FDA Inspection 1193806 - Chartwell Pharmaceuticals Amityville, LLC - 2022-12-21](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-amityville-llc/835d60f1-5c38-4d3e-8413-2adfc3e91dcb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 21, 2022
- [483 - Chartwell Pharmaceuticals Amityville, LLC - 2019-02-13](https://www.keypedia.com/records/483/chartwell-pharmaceuticals-amityville-llc/d1cdf69f-9f0a-4fe6-94a0-1cbc864a8338) — source: FDA, date: February 13, 2019
- [FDA Inspection 1079804 - Chartwell Pharmaceuticals Amityville, LLC - 2019-02-13](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-amityville-llc/1c53ee15-e167-46c5-98e7-344d71a01d00) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2019
- FDA Inspection 1020105 - Chartwell Pharmaceuticals Amityville, LLC - 2017-07-20 — source: FDA, date: July 20, 2017
- [FDA Inspection 1011507 - Chartwell Pharmaceuticals Amityville, LLC - 2017-05-05](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-amityville-llc/62c85bc8-69bd-45a0-a590-99f38b6f85bd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 5, 2017
- [FDA Inspection 980564 - Chartwell Pharmaceuticals Amityville, LLC - 2016-07-15](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-amityville-llc/ff7a3f71-f40d-4370-920b-b24092eaabd4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2016
- [FDA Inspection 935584 - Chartwell Pharmaceuticals Amityville, LLC - 2015-07-20](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-amityville-llc/0a358af1-6afb-4c29-b790-de0e14d3add5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 20, 2015
- [FDA Inspection 855253 - Chartwell Pharmaceuticals Amityville, LLC - 2013-10-30](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-amityville-llc/cc2cbf70-29c8-48df-98a0-7c95c7022707) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2013
- FDA Inspection 855253 - Chartwell Pharmaceuticals Amityville, LLC - 2013-10-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2013
- FDA Inspection 862838 - Chartwell Pharmaceuticals Amityville, LLC - 2013-10-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2013

## Related Companies

- [Sagent Pharmaceuticals](https://www.keypedia.com/companies/sagent-pharmaceuticals/9b7830c1-51dd-4d82-8287-b320eff537fd)
- [AltaSciences Clinical Los Angeles Inc.](https://www.keypedia.com/companies/altasciences-clinical-los-angeles-inc/977107a9-0682-40d1-b775-8c0cb8c7e822)
- [David L. Wirta, M.D.](https://www.keypedia.com/companies/david-l-wirta-md/f239b2b9-d44b-4aa0-b2e3-3506e3831bae)
- [Nesher Pharmaceuticals (USA) LLC](https://www.keypedia.com/companies/nesher-pharmaceuticals-usa-llc/d0fd36a5-057e-46eb-8fb3-828cd2c27388)
- [Bausch Health Americas, Inc.](https://www.keypedia.com/companies/bausch-health-americas-inc/46368cf4-fd1b-4ed0-a010-ae5ccd022cb6)
- [BioTel Research, LLC](https://www.keypedia.com/companies/biotel-research-llc/2a9f13e0-a9ee-4e1b-a154-2190996d80db)
- [Taro Pharmaceuticals U.S.A., Inc.](https://www.keypedia.com/companies/taro-pharmaceuticals-usa-inc/05da273e-af73-473f-a144-af7c4e2972c9)
- [Cody Laboratories, Inc.](https://www.keypedia.com/companies/cody-laboratories-inc/ff687af7-da97-441d-b0cd-7f20af5e87a9)
- [Pfizer Inc.](https://www.keypedia.com/companies/pfizer-inc/95f0f34c-638b-4a6b-8c65-35fb37711e6b)
- [Gilead Sciences Inc](https://www.keypedia.com/companies/gilead-sciences-inc/25d591ee-1217-4ca3-9134-ed69477f677f)

## Related Officers

- [investigator](https://www.keypedia.com/people/jay-wong/d58065c6-6c52-4d77-af6b-089176c778c9)
- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [Investigator](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
